GMDA Gross Margin

The Gross Margin of Gamida Cell Ltd (GMDA) is 18.50%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

GMDA Gross Margin - Historical Value

Date	Value
2023-12-31	18.50%

GMDA Gross Margin - Peers Comparison

Ticker	Name	Value
APS.TO	Aptose Biosciences Inc	100.00%
AUTL	Autolus Therapeutics PLC	-6.37%
VKTX	Viking Therapeutics Inc	7775.20%
AVRO	AVROBIO Inc	7775.20%
BLRX.TA	BioLine RX Ltd	67.99%
CBI.TA	Clal Biotechnology Industries Ltd	59.63%
KMDA	Kamada Ltd	43.47%
RAPT	Rapt Therapeutics Inc	7775.20%
CLGN	Collplant Biotechnologies Ltd	-160.00%
ENLV	Enlivex Therapeutics Ltd	7775.20%
OCX	OncoCyte Corp	39.34%
CRNX	Crinetics Pharmaceuticals Inc	7775.20%
ONCT	Oncternal Therapeutics Inc	91.24%
ALDX	Aldeyra Therapeutics Inc	7775.20%
BCYC	Bicycle Therapeutics PLC	7775.20%
BONS.TA	Bonus Biogroup Ltd	10.93%
CMMB	Chemomab Therapeutics Ltd	7775.20%
URGN	Urogen Pharma Ltd	90.18%
AGLE	Aeglea Bio Therapeutics Inc	7775.20%
FHTX	Foghorn Therapeutics Inc.	7775.20%
GERN	Geron Corp	98.37%
INZY	Inozyme Pharma Inc	7775.20%
ISEE	IVERIC bio Inc	7775.20%
SPRO	Spero Therapeutics Inc	7775.20%
ACET	Adicet Bio Inc	7775.20%
BYSI	Beyondspring Inc	7775.20%
SELB	Selecta Biosciences Inc	7775.20%
SMMT	Summit Therapeutics Inc	99.95%
SNSE	Sensei Biotherapeutics Inc	7775.20%
APLT	Applied Therapeutics Inc	7775.20%
BLU.TO	BELLUS Health Inc	7775.20%
ETNB	89Bio Inc	7775.20%
NLTX	Neoleukin Therapeutics Inc	7775.20%
SPRB	Spruce Biosciences Inc	7775.20%